215 related articles for article (PubMed ID: 22874492)
1. [Summarizing of medicinal alerts in Ivory Coast from 2001 till 2010].
N'Guessan-Irié AG; Yavo JC; Guillaume Amari AS; Yapi AD
Therapie; 2012; 67(3):251-6. PubMed ID: 22874492
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
N'Guessan-Irié AG; Yavo JC; Amari AS; Yapi AD
Therapie; 2012; 67(3):251-6. PubMed ID: 27392427
[TBL] [Abstract][Full Text] [Related]
3. Updating the French method for the causality assessment of adverse drug reactions.
Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
[TBL] [Abstract][Full Text] [Related]
4. [Update of the French drug reaction assessment method].
; Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB
Therapie; 2011; 66(6):517-25. PubMed ID: 22186077
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacovigilance in practice].
Spreux A; Baldin B; Chichmanian RM
Transfus Clin Biol; 1999 Jul; 6(4):254-9. PubMed ID: 10472690
[TBL] [Abstract][Full Text] [Related]
6. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
Olivier P; Montastruc JL
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
[TBL] [Abstract][Full Text] [Related]
7. [Terappel: description of a computerised database and examples of studies].
Vial T; Gouraud A; Bernard N
Therapie; 2014; 69(1):31-8. PubMed ID: 24698186
[TBL] [Abstract][Full Text] [Related]
8. [Organization and results of drug vigilance in France].
Bégaud B; Chaslerie A; Haramburu F
Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
[TBL] [Abstract][Full Text] [Related]
9. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
10. Grouping the pharmacovigilance terms with a hybrid approach.
Dupuch M; Dupuch L; Perinet A; Hamon T; Grabar N
Stud Health Technol Inform; 2012; 180():235-9. PubMed ID: 22874187
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants].
Castot A; Djezzar S; Deleau N; Guillot B; Efthymiou ML
Therapie; 1997; 52(2):97-103. PubMed ID: 9231502
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
13. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
Fleuranceau-Morel P
Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
[TBL] [Abstract][Full Text] [Related]
14. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].
Aguirre C; Haramburu F
Therapie; 1995; 50(6):563-9. PubMed ID: 8745957
[TBL] [Abstract][Full Text] [Related]
15. Pharmacovigilance in Europe and North America: divergent approaches.
Wiktorowicz M; Lexchin J; Moscou K
Soc Sci Med; 2012 Jul; 75(1):165-70. PubMed ID: 22521677
[TBL] [Abstract][Full Text] [Related]
16. On the clinical evidence leading to tetrazepam withdrawal.
Proy-Vega B; Aguirre C; de Groot P; Solís-García del Pozo J; Jordán J
Expert Opin Drug Saf; 2014 Jun; 13(6):705-12. PubMed ID: 24845943
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reaction monitoring and the Internet: evaluation of the use of the Internet by French Pharmacovigilance Centres and a non-exhaustive survey of websites of interest for collecting information about adverse drug reaction.
Morel P; Vandel B
Therapie; 1999; 54(5):525-32. PubMed ID: 10667084
[TBL] [Abstract][Full Text] [Related]
18. [The French pharmacovigilance system: structure and missions].
Welsch M; Alt M; Richard MH; Imbs JL
Presse Med; 2000 Jan; 29(2):102-6. PubMed ID: 10682040
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of computer-aided disproportionality analysis for post-marketing signal detection.
Lehman HP; Chen J; Gould AL; Kassekert R; Beninger PR; Carney R; Goldberg M; Goss MA; Kidos K; Sharrar RG; Shields K; Sweet A; Wiholm BE; Honig PK
Clin Pharmacol Ther; 2007 Aug; 82(2):173-80. PubMed ID: 17507922
[TBL] [Abstract][Full Text] [Related]
20. ["Serious" adverse drug reactions with tramadol: a 2010-2011 pharmacovigilance survey in France].
Abadie D; Durrieu G; Roussin A; Montastruc JL;
Therapie; 2013; 68(2):77-84. PubMed ID: 23773348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
